Overview

PK Study in 3- to 6- Month-Old Children (0476-268)(COMPLETED)

Status:
Completed

Trial end date:
2003-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to look at the preliminary safety profile of an investigational drug in children 3 to 6 months of age with bronchiolitis.

Phase:

Phase 2

Details

Lead Sponsor:

Merck Sharp & Dohme Corp.

Treatments:

Montelukast